Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

antares pharma

POPULAR ARTICLES

pharmaceutical investing

Antares Pharma Reports Q4 and Full Year 2019 Financial Results

Antares Announces 2020 Revenue Guidance Range of up to US$155 Million

NASDAQ:ATRS

medical device investing

Antares’ Device Aids Teva’s Generic EpiPen Launch

LATEST ARTICLES

Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen

pharmaceutical investing

Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy

pharmaceutical investing

Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector

Latest News

1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

Brunswick Exploration Completes Brokered Private Placement for Gross Proceeds of C$3.5 Million

Juggernaut Files for Final Approval of Oversubscribed Financing

Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results